WilmerHale Represents Kinnevik in Transformational Transaction with VillageMD and Walgreens Boots Alliance

Download IconDownload Print IconPrint

WilmerHale Represents Kinnevik in Transformational Transaction with VillageMD and Walgreens Boots Alliance

Firm News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

Kinnevik, a leading European growth investor, announced its support for a transaction in which Walgreens Boots Alliance (WBA) will invest an additional $5.2 billion in Kinnevik portfolio company VillageMD. As part of this transformational transaction, Kinnevik has committed to sell part of its stake in VillageMD for a minimum of $340 million. Kinnevik expects to retain an approximate 4% stake in VillageMD, valued at approximately $535 million depending on the final size of Kinnevik’s sale. The transaction is subject to customary regulatory approvals and closing conditions and is expected to close in the fourth quarter of 2021.

VillageMD is a leading, national provider of value-based primary care services. With WBA’s investment, VillageMD can accelerate its strategy of providing comprehensive, coordinated care through its value-based primary care model. This strategy includes expanding into broader service lines and allowing higher engagement with individuals managing chronic conditions or who need an additional level of care.

The WilmerHale team representing Kinnevik included Adam Freiman, Bill Caporizzo and Kate Leonard. WilmerHale has represented Kinnevik since its initial investment in VillageMD in 2019.

 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel